Related Experiment Video
Updated: Aug 8, 2026

Sucrose Preference and Novelty-Induced Hypophagia Tests in Rats using an Automated Food Intake Monitoring System
Published on: May 8, 2020
Depression and consumption: psychopharmaceuticals, branding, and new identity practices
1Program in Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. npg@mit.edu
Abstract:
As pharmaceuticals are moving from private patient-doctor conversations to public television and print advertisements, best-selling books, and top TV shows, as well as into everyday conversations around risk and illness, how people understand health, sickness, and their own identity is also changing. This paper explores some of these changes by unpacking some of the social, political, and personal layers that are complicating the production and marketing of prescription drugs, and that are transforming the identity practices around contested illness. I focus on Sarafem and premenstrual dysphoric disorder (the illness Sarafem was marketed for) as a case study.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
The Placebo Effect
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Drug Dependence
Deindividuation

